130 related articles for article (PubMed ID: 8617331)
21. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
[TBL] [Abstract][Full Text] [Related]
22. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.
Daly TM; Long CA
Infect Immun; 1993 Jun; 61(6):2462-7. PubMed ID: 8363656
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium berghei merozoite surface protein-9: immunogenicity and protective efficacy using a homologous challenge model.
Lopera-Mesa TM; Kushwaha A; Mohmmed A; Chauhan VS
Vaccine; 2008 Mar; 26(10):1335-43. PubMed ID: 18272263
[TBL] [Abstract][Full Text] [Related]
24. Expression, localization, and erythrocyte binding activity of Plasmodium yoelii merozoite surface protein-8.
Shi Q; Cernetich-Ott A; Lynch MM; Burns JM
Mol Biochem Parasitol; 2006 Oct; 149(2):231-41. PubMed ID: 16846654
[TBL] [Abstract][Full Text] [Related]
25. Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.
Daly TM; Long CA
Infect Immun; 1996 Jul; 64(7):2602-8. PubMed ID: 8698485
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.
Sharma SK; Gupta C; Dwivedi V; Misra-Bhattacharya S; Mohammad O
Vaccine; 2007 Mar; 25(11):2103-11. PubMed ID: 17241709
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.
Kedzierski L; Black CG; Stowers AW; Goschnick MW; Kaslow DC; Coppel RL
Vaccine; 2001 Sep; 19(32):4661-8. PubMed ID: 11535314
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
[TBL] [Abstract][Full Text] [Related]
29. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii.
Burns JM; Parke LA; Daly TM; Cavacini LA; Weidanz WP; Long CA
J Immunol; 1989 Apr; 142(8):2835-40. PubMed ID: 2467942
[TBL] [Abstract][Full Text] [Related]
30. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
Xu L; Pei X; Berzins K; Chaudhuri A
Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
[TBL] [Abstract][Full Text] [Related]
32. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
[TBL] [Abstract][Full Text] [Related]
33. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
Petritus PM; Burns JM
J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
[TBL] [Abstract][Full Text] [Related]
34. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.
ten Hagen TL; Sulzer AJ; Kidd MR; Lal AA; Hunter RL
J Immunol; 1993 Dec; 151(12):7077-85. PubMed ID: 8258712
[TBL] [Abstract][Full Text] [Related]
35. Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria.
Mello K; Daly TM; Long CA; Burns JM; Bergman LW
Infect Immun; 2004 Feb; 72(2):1010-8. PubMed ID: 14742548
[TBL] [Abstract][Full Text] [Related]
36. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.
Tian JH; Kumar S; Kaslow DC; Miller LH
Infect Immun; 1997 Aug; 65(8):3032-6. PubMed ID: 9234750
[TBL] [Abstract][Full Text] [Related]
37. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
Matsumoto S; Yukitake H; Kanbara H; Yamada T
J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
[TBL] [Abstract][Full Text] [Related]
38. Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice.
Miyata T; Harakuni T; Taira T; Matsuzaki G; Arakawa T
Vaccine; 2012 Jan; 30(5):948-58. PubMed ID: 22119928
[TBL] [Abstract][Full Text] [Related]
39. Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia.
Spencer Valero LM; Ogun SA; Fleck SL; Ling IT; Scott-Finnigan TJ; Blackman MJ; Holder AA
Infect Immun; 1998 Aug; 66(8):3925-30. PubMed ID: 9673281
[TBL] [Abstract][Full Text] [Related]
40. Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.
Leite JA; Bargieri DY; Carvalho BO; Albrecht L; Lopes SC; Kayano AC; Farias AS; Chia WN; Claser C; Malleret B; Russell B; Castiñeiras C; Santos LM; Brocchi M; Wunderlich G; Soares IS; Rodrigues MM; Rénia L; Costa FT
Infect Immun; 2015 Oct; 83(10):3781-92. PubMed ID: 26169268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]